This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Gene Sequencing Remove Genomics Remove Licensing Related Topics
DNA Genome Licensing Gene Allergies RNA Vaccine Vaccination Development Research More Related Topics >
article thumbnail

Boost for mRNA as Moderna to acquire OriCiro for $85 million

pharmaphorum

JANUARY 5, 2023

and OriCiro Genomics K.K. Nonetheless, Moderna has previously been involved in licensing deals to advance its technology. The data was from their phase 2b trial of a personalised vaccine consisting of 34 mRNAs, each targeting mutations – identified by gene sequencing – thought to be driving a patient’s cancer.

Gene Sequencing 79
Gene Sequencing DNA Vaccination Vaccine 79
article thumbnail

Oxford Nanopore makes stellar debut on UK stock market

pharmaphorum

OCTOBER 1, 2021

It may also use the cash injection for “in-licensing opportunities and potential acquisitions”, according to the document. Chief technology officer Clive Brown is also sitting on a £10 million stake. The post Oxford Nanopore makes stellar debut on UK stock market appeared first on.

Marketing 52
Marketing Business Development Genome Genomics 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024